New Blog Series: Design and Implementation of an Effective Potent Compound Program

Over the next several months on this blog I will be covering a new series on the “Design and Implementation of an Effective Potent Compound Safety Program.” This series will largely follow the content of the article that was published by Dr. Joe Nieusma and myself in the October, 2007 issue of ContractPharma. In this series I will cover the following topics:

Definition of a Potent Compound

Anticipation: understanding the drug development process, conducting a preliminary risk assessment, literature sources, and potent compound categorization.

Recogniton: recognizing activities with exposure potential, recognizing hazards of active pharmaceutical ingredients (APIs)

Evaluation: conducting a walkthrough survey, industrial hygiene monitoring for APIs, wipe sampling, etc.

Control: control banding in the pharmaceutical industry, engineering controls, administrative controls, and personal protective equipment.

Throughout this series we will go into greater detail and depth than what was possible in the magazine. In addition, where possible we will provide links to technical resources that are within the public domain.

Upcoming Webinars

July 9th, 2008: Methylene Chloride Safety
July 10th to August 7th (every Thursday): Advanced Topics in Potent Compounds
July 15th: Isoflurane Safety

Click on any of the above links for specific times and to register. If you have any questions about our webinars please contact Affygility Solutions.


About Dean Calhoun

view all posts

Dean is the President and CEO of Affygility Solutions. Affygility Solutions provides environmental, health and safety software, potent compound safety, industrial hygiene, containment validation services to the pharmaceutical, biotechnology, and medical device industry. "Dean's Google+ Profile"

Affygility Solutions - provider of potent compound safety, webinars, and compliance management software